Processing Principles in Surgical Pathology

Processing Principles in Surgical Pathology

By Julio Diaz-Perez, Jorge Garcia-Vera

View this Author's Spotlight

Paperback, 384 pages 

 (3 Ratings)

Preview

Price:	$30.00

Ships in 3–5 business days

This book is focused in general pathology and modalities for management, sampling and reporting of surgical specimens in order to establish common rules for defining the prognosis and treatment of various illnesses.

Add to Cart

 

EmailEmbed

Ratings & Reviews | Product Details

 

Ratings & Reviews

Log In to review this item

Lulu Sales Rank: 188286

Log In to rate this item

Not Yet Rated 

2 People Reviewed This Item

Nov. 21, 2011

Dear Readers. I highly recommend this book as a educational tool for pathologist and surgeons in training. I have had the opportunity to read this book and I consider this book meets the most relevant topics and elements in the study of surgical pathology. The illustrations and diagrams have a great quality and help the readers to understand concepts easily and the price of the book is really affordable.

Report as inappropriate

Nov. 21, 2011

I think the authors did an excellent job with this book. Its very easy to understand each chapter, and also has magnificent pathological illustrations.

Report as inappropriate

Product Details

ISBN	978-1-105-26625-6
Copyright	Julio A. Diaz-Perez and Jorge A. Garcia-Vera (Standard Copyright License)
Edition	First Edition
Language	English
Pages	384
Binding	Perfect-bound Paperback
Interior Ink	Black & white
Dimensions (inches)	8.5 wide × 11.0 tall

http://www.lulu.com/product/paperback/processing-principles-in-surgical-pathology/18683571

The Role of Genetics in Personalised Medicine

Professor Griffiths is a medical researcher who has been studying the genes involved in common human disorders for nearly two decades. Her expertise is in the field of human gene mapping and molecular genetics. 

Tutorial for analysis complex diseases with IPA

Targeting the Phosphoinositide-3 Kinase (PI3K) Pathway in Breast Cancer

This podcast reviews current data related to the phosphoinositide-3 kinase (PI3K) pathway, its role in breast cancer, the frequently with which PI3K is aberrant in breast cancer, and the potential clinical implications of using agents that target the PI3K pathway. Jose Baselga is the Chief of the Division of Hematology/Oncology and Associate Director of the Massachusetts General Hospital Cancer Center in Boston where he is also Professor of Medicine at Harvard Medical School. His research interests are in clinical breast cancer and in translational and early clinical research. He conducted the initial clinical trials with the monoclonal antibodies cetuximab and trastuzumab and is leading the clinical development of several new agents including pertuzumab and PI3K inhibitors. His main focus in the laboratory and in the clinic is in the area of novel anti-HER2 agents, in the identification of mechanisms of resistance to anti-HER2 agents and therapeutic approaches to target the PI3K pathway. He is also leading a number of neo-adjuvant trials in breast cancer and has been at the forefront of developing biomarker-based early and translational clinical trials.

Personalized Medicine and Cancer Research

Dr. Sonali Smith discusses personalized medicine and how it is helping shape current and future cancer research. Sonali Smith, MD is Associate Professor of Medicine at the University of Chicago Medical Center.

Traditional Therapies to Modern Medicine

Vikas Sukhatme, M.D., Ph.D., presented this lecture as part of the Stephen E. Straus Distinguished Lecture in the Science of Complementary and Alternative Medicine series. Dr. Sukhatme talks about the availability of existing scientifically promising, affordable, and immediately available medical treatments. Traditional medicines have a long history of use and efficacy and offer viable options in addressing other conditions, including cancer. Among these traditions is lifestyle manipulation, specifically dietary adjustments and stress reduction/control, both of which show promise in treating certain forms of cancer. Though more research is needed, Dr. Sukhatme realizes the importance and benefits of studying existing therapies for application to other medical conditions     Dr. Sukhatme's research has spanned numerous basic science and clinical arenas, including the discovery of a family of mammalian transcription factors induced by extracellular growth and differentiation cues, and studies on the function of several genes important in kidney cancer and in polycystic kidney disease. His major current interest is in tumor metabolism and tumor immunology and on "outside-the-box" approaches to therapies for advanced cancer.  Dr. Sukhatme is the Victor J. Aresty Professor of Medicine, Harvard Medical School, Chief Academic Officer and Harvard Faculty Dean for Academic Programs, Beth Israel Deaconess Medical Center.

Your First Mammogram: What to Expect

In this MD Anderson video the mammogram is explained, a mammogram is one of the most effective screening tools available to detect and diagnose breast cancer. Learn what to expect during this important cancer screening test.

Discussion about robotics in surgery and cancer therapy

Host Harry Kreisler welcomes artist and engineer Ken Goldberg from Berkeley. Goldberg discusses robotics in surgery and cancer therapy, and their application in disasters and on the battlefield. Describing several of his recent art projects, Goldberg then discusses complementarities with his engineering research and reflects on the philosophical implications of 'telepresence.' 

On the verge of creating synthetic life

"Can we create new life out of our digital universe?" asks Craig Venter. And his answer is, yes, and pretty soon. He walks the TED2008 audience through his latest research into "fourth-generation fuels" -- biologically created fuels with CO2 as their feedstock. His talk covers the details of creating brand-new chromosomes using digital technology, the reasons why we would want to do this, and the bioethics of synthetic life

Lung Cardiac and Colon Screening with CT

CT scanning, also called CAT scanning, is a noninvasive medical test that helps physicians diagnose and treat medical conditions. Drs. Fergus Coakley, Brett Elicker, and Judy Yee, UCSF Department of Radiology, explore the risks and benefits of lung, heart and colon screenings with CT.